SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) announced that its Board of Directors is conducting a review of strategic options ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE